[
    [
        {
            "time": "2018-08-19",
            "original_text": "格隆汇港股聚焦(8.19)︱雅生活服务中期核心净利增逾四成；阿里巴巴明日公布Q1业绩",
            "features": {
                "keywords": [
                    "雅生活服务",
                    "中期核心净利",
                    "增长",
                    "阿里巴巴",
                    "Q1业绩"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "房地产服务",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "格隆汇港股聚焦(8.19)︱雅生活服务中期核心净利增逾四成；阿里巴巴明日公布Q1业绩",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-08-19",
            "original_text": "上海医药(02607.HK)糠酸莫米松富马酸福莫特罗吸入气雾剂获得临床试验批准",
            "features": {
                "keywords": [
                    "上海医药",
                    "糠酸莫米松富马酸福莫特罗吸入气雾剂",
                    "临床试验",
                    "批准"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海医药(02607.HK)糠酸莫米松富马酸福莫特罗吸入气雾剂获得临床试验批准",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-08-19",
            "original_text": "药明系第三家上市公司：药明巨诺能否重演药明康德传奇？",
            "features": {
                "keywords": [
                    "药明巨诺",
                    "上市",
                    "药明康德"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "药明系第三家上市公司：药明巨诺能否重演药明康德传奇？",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-08-19",
            "original_text": "上海医药(601607.SH)：全资子公司“糠酸莫米松富马酸福莫特罗吸入气雾剂”获批临床",
            "features": {
                "keywords": [
                    "上海医药",
                    "糠酸莫米松富马酸福莫特罗吸入气雾剂",
                    "临床试验",
                    "全资子公司"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海医药(601607.SH)：全资子公司“糠酸莫米松富马酸福莫特罗吸入气雾剂”获批临床",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-08-19",
            "original_text": "上海医药：子公司药品获得临床试验批准通知书",
            "features": {
                "keywords": [
                    "上海医药",
                    "子公司",
                    "药品",
                    "临床试验",
                    "批准通知书"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海医药：子公司药品获得临床试验批准通知书",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-08-19",
            "original_text": "本月即将开标 关注大品种竞争格局重构",
            "features": {
                "keywords": [
                    "开标",
                    "大品种",
                    "竞争格局",
                    "重构"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "招投标"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "本月即将开标 关注大品种竞争格局重构",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-08-19",
            "original_text": "两知名药企，宣布联手了",
            "features": {
                "keywords": [
                    "知名药企",
                    "联手"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "两知名药企，宣布联手了",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]